title: Human peritoneal mesothelial cells are more potent than ovarian cancer cells in producing tumor marker CA-125.
abstract: The aim of the present study was to investigate the extent to which human peritoneal mesothelial cells (HPMCs) are able to participate in the release of tumor marker CA-125 in ovarian cancer and other conditions associated with an involvement of the peritoneum. For this purpose CA-125 shedding was measured in the supernatant culture medium of HPMCs obtained from various donors and seven well-established ovarian cancer cell lines (OVCAR-3, 2780, 2774, SKOV-6, SKOV-8, HOC-7, HTB-77). Furthermore, the influence of inflammatory cytokines [interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF-alpha), interferon gamma (IFN-gamma)] on CA-125 release in normal and malignant cells was also studied. Constitutive CA-125 shedding was found to be about five times higher in HPMCs as compared with the investigated ovarian cancer cell lines. IL-1 beta and TNF-alpha treatment of HPMCs resulted in a significant reduction in CA-125 release; however, no consistent pattern in CA-125 secretion was found during incubation with either IL-1 beta or TNF-alpha in the various malignant cell lines. IFN-gamma, on the other hand, induced a highly significant increase in CA-125 secretion in ovarian cancer cells, but did not influence the shedding of CA-125 in HPMCs.
authors.affiliation: Department of Obstetrics and Gynecology, University Hospital, University of Innsbruck, Austria.
authors.forename: A G
authors.initials: AG
authors.lastname: Zeimet
authors.forename: C
authors.initials: C
authors.lastname: Marth
authors.forename: F A
authors.initials: FA
authors.lastname: Offner
authors.forename: P
authors.initials: P
authors.lastname: Obrist
authors.forename: M
authors.initials: M
authors.lastname: Uhl-Steidl
authors.forename: H
authors.initials: H
authors.lastname: Feichtinger
authors.forename: S
authors.initials: S
authors.lastname: Stadlmann
authors.forename: G
authors.initials: G
authors.lastname: Daxenbichler
authors.forename: O
authors.initials: O
authors.lastname: Dapunt
mesh_terms: D018394:CA-125 Antigen / Q000096:biosynthesis*; D002455:Cell Division / Q000187:drug effects / Q000502:physiology; D002478:Cells, Cultured; D016207:Cytokines / Q000494:pharmacology; D004847:Epithelial Cells; D004848:Epithelium / Q000378:metabolism; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology; D010051:Ovarian Neoplasms / Q000378:metabolism* / Q000473:pathology*; D010529:Peritoneal Cavity / Q000166:cytology*; D014407:Tumor Cells, Cultured; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology
chemical_list: D018394:CA-125 Antigen; D016207:Cytokines; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma